$5.70
-0.14 (-2.40%)
ZymoGenetics, Inc. (ZGEN)
CAPS Rating:
The Company is focused on the discovery, development, manufacture and commercialization of therapeutic proteins for the treatment of human diseases.

RSS Headlines
Fool UK